Arcturus Therapeutics Holdings Inc's Company Valuation
Currency: USD Updated: 2026-08-07
Previous score
7.35
Change
-0.24
The current valuation score of Arcturus Therapeutics Holdings Inc is 7.11, ranking 241 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.62, which is -2576.26% below the recent high of 64.80 and -1371.56% above the recent low of -38.51.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.